• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,245.91 45.04
(0.09%)
Dow Jones
7,786.38 -36.39
(-0.47%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.67 0.30
(0.31%)
EUR-INR
108.31 -0.02
(-0.02%)
GBP-INR
127.86 0.18
(0.14%)
JPY-INR
0.61 0.00
(0.24%)

EQUITY - MARKET SCREENER

Bacil Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524516
INE711D01018
17.5541002
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
52.63
34.75
EPS(TTM)
Face Value()
Div & Yield %
0.46
10
0
 

Basilic Fly Studio consolidated net profit declines 18.56% in the March 2026 quarter
May 30,2026
Net profit of Basilic Fly Studio declined 18.56% to Rs 13.60 crore in the quarter ended March 2026 as against Rs 16.70 crore during the previous quarter ended March 2025. Sales declined 15.12% to Rs 113.40 crore in the quarter ended March 2026 as against Rs 133.60 crore during the previous quarter ended March 2025.

For the full year,net profit rose 33.70% to Rs 48.80 crore in the year ended March 2026 as against Rs 36.50 crore during the previous year ended March 2025. Sales rose 34.10% to Rs 407.80 crore in the year ended March 2026 as against Rs 304.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales113.40133.60 -15 407.80304.10 34
OPM %21.0824.40 -20.8923.51 -
PBDT26.2030.50 -14 85.7067.30 27
PBT20.9027.00 -23 69.4055.10 26
NP13.6016.70 -19 48.8036.50 34